Panagopoulos Ioannis, Gorunova Ludmila, Torkildsen Synne, Tjønnfjord Geir E, Micci Francesca, Heim Sverre
Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Cancer Genomics Proteomics. 2017 Nov-Dec;14(6):437-443. doi: 10.21873/cgp.20053.
BACKGROUND/AIM: Given the diagnostic, prognostic, biologic, and even therapeutic impact of leukemia-associated translocations and fusion genes, it is important to detect cryptic genomic rearrangements that may exist in hematological malignancies.
RNA-sequencing was performed on an acute myeloid leukemia case with the bone marrow karyotype 45,X,-Y,t(9;12) (q34;q15)[16].
The DEK-NUP214 and PRRC2B-DEK fusion genes were found. Reverse transcriptase polymerase chain reaction together with direct sequencing verified the presence of both. Fluorescence in situ hybridization showed that the DEK-NUP214 fusion gene was located on the 6p22 band of a seemingly normal chromosome 6.
RNA-sequencing proved to be a valuable tool for the detection of a fusion of genes DEK and NUP214 in a leukemia that showed cryptic cytogenetic rearrangement of chromosome band 9q34.
背景/目的:鉴于白血病相关易位和融合基因在诊断、预后、生物学乃至治疗方面的影响,检测血液系统恶性肿瘤中可能存在的隐匿性基因组重排非常重要。
对一例骨髓核型为45,X,-Y,t(9;12)(q34;q15)[16]的急性髓系白血病病例进行了RNA测序。
发现了DEK-NUP214和PRRC2B-DEK融合基因。逆转录聚合酶链反应结合直接测序证实了两者的存在。荧光原位杂交显示DEK-NUP214融合基因位于一条看似正常的6号染色体的6p22带上。
RNA测序被证明是检测在9q34染色体带显示隐匿性细胞遗传学重排的白血病中DEK和NUP214基因融合的有价值工具。